Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spero Therapeutics (SPRO) Preferred Shares (2020 - 2022)

Spero Therapeutics (SPRO) has disclosed Preferred Shares for 3 consecutive years, with $2000.0 as the latest value for Q2 2022.

  • For the quarter ending Q2 2022, Preferred Shares fell 33.33% year-over-year to $2000.0, compared with a TTM value of $2000.0 through Jun 2022, down 33.33%, and an annual FY2021 reading of $3000.0, changed 0.0% over the prior year.
  • Preferred Shares was $2000.0 for Q2 2022 at Spero Therapeutics, down from $3000.0 in the prior quarter.
  • Across five years, Preferred Shares topped out at $3000.0 in Q3 2020 and bottomed at $2000.0 in Q2 2022.
  • Average Preferred Shares over 3 years is $2875.0, with a median of $3000.0 recorded in 2020.
  • The sharpest move saw Preferred Shares changed 0.0% in 2021, then tumbled 33.33% in 2022.
  • Year by year, Preferred Shares stood at $3000.0 in 2020, then changed by 0.0% to $3000.0 in 2021, then tumbled by 33.33% to $2000.0 in 2022.
  • Business Quant data shows Preferred Shares for SPRO at $2000.0 in Q2 2022, $3000.0 in Q1 2022, and $3000.0 in Q4 2021.